Skip to content
Syntegon
-
Syntegon achieves record 2025 results as pharmaceutical innovation drives 22% growth
The company grew revenue by 10% to EUR 1.75 billion (USD1.91 billion) while substantially improving profitability and cash generation.
-
Apollo acquires 37% stake in Syntegon from CVC Capital Partners
The transaction, which remains subject to customary regulatory approvals, marks the beginning of what both firms describe as Syntegon’s next major growth phase.
-
LYOCONTRACT invests USD54M in new freeze-drying facility in Germany
LYOCONTRACT has partnered with Syntegon, a leading equipment supplier, to install a complete filling and lyophilization line at the new facility.
-
Syntegon launches AIM9 platform to transform pharmaceutical vial inspection
The platform integrates visual inspection capabilities with advanced leak detection technology, processing up to 600 vials per minute while maintaining rigorous quality standards.
-
Syntegon reports 19% sales growth in Q3 2025 driven by pharma innovation
The company’s Pharma business unit led the strong performance, delivering sales growth of 32%, including 20% organic growth.